Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 38,120 shares at $14.45 ($554K) on 2026-04-01, disclosed to the SEC on 2026-04-02.
Scheduled sale ($554k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.45 | 19,060 | $275K | 49.7% |
| 2 | $14.60 | 19,060 | $278K | 50.3% |
| Total | $14.53 avg | 38,120 | $554K | 100% |
| Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |
| ADPT | SELL | 2026-04-21 | $1.0M | — | Filing → |